Exchange Announcement • 13 Feb 2024 05:48
Exchange Announcement • 13 Feb 2024 05:48
Exchange Announcement • 13 Feb 2024 05:47
Exchange Announcement • 13 Feb 2024 05:46
Exchange Announcement • 13 Feb 2024 05:45
ENTITY
Immunogen Inc (IMGN US)
Immunogen Inc (IMGN US)
12
Analysis
Health Care • United States
ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.
more
x